Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,954,238
+$4,801,598 QoQ
Shares Held
1,125,748
-10.5% QoQ
Ownership
0.704%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#35
of 290 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Mar 31, 2026CallValue
$288,000
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. DNLI ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in DNLI
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,954,238 | 1,125,748 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $288,000 | 15,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $24,152,640 | 1,257,950 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,104,853 | 369,767 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,980,122 | 1,307,171 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,598,008 | 900,501 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,298,259 | 1,493,068 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,238,085 | 404,224 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,752,693 | 60,168 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,394,751 | 619,929 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,015,440 | 390,616 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $2,441,581 | 118,351 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,111,268 | 478,186 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,900,098 | 386,289 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,262,156 | 297,093 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,227,886 | 496,184 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,992,238 | 645,336 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $818,856 | 18,360 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,110,928 | 41,842 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,102,412 | 52,300 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $1,525,108 | 19,443 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $840,055 | 14,712 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $3,711,500 | 65,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $4,188,000 | 50,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $486,980 | 5,814 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,575,061 | 127,688 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $539,431 | 22,309 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||